The Medication Myth Your Doctor Isn't Allowed to Tell You: Why Your Prescription is Only Half the Story
You leave the doctor's office with a script in hand, a plan in mind, and hope for a cure. You take the pill faithfull...
CYTOSAR-U INJECTION 20mg/ml (5ml vial) (Cytarabine)
$19.25
Active Ingredient : Cytarabine
Discover the benefits of CYTOSAR-U INJECTION 20mg/ml, a potent cytarabine solution designed for effective chemotherapy treatment, helping to manage various types of cancer with precision and care.
Reliable shipping
Flexible returns
Dispensing Country : India
CYTOSAR-U INJECTION 20mg/ml (5ml vial), containing Cytarabine, is a potent chemotherapy medication primarily used in the treatment of various forms of leukemia, including acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). It is also effective in managing certain types of lymphoma and as part of conditioning regimens before bone marrow transplantation. Cytarabine works by interfering with the synthesis of DNA, thereby inhibiting the growth and proliferation of cancer cells.
This injection is administered intravenously or subcutaneously, depending on the treatment protocol prescribed by a healthcare professional. The dosage and duration of therapy are tailored to the patient's specific condition, weight, and overall health status. It is crucial to follow the prescribed regimen closely to maximize therapeutic efficacy while minimizing potential side effects.
Patients using CYTOSAR-U may experience side effects such as nausea, vomiting, diarrhea, loss of appetite, and fatigue. More severe reactions can include bone marrow suppression, leading to decreased blood cell counts, increased risk of infections, and bleeding complications. Regular monitoring of blood counts and liver function is essential during treatment to manage these risks effectively.
Storage of CYTOSAR-U requires refrigeration at 2°C to 8°C (36°F to 46°F), and the solution should be protected from light. Once opened, the vial should be used immediately to ensure the stability and potency of the medication. It is important to handle this medication with care, as it is a cytotoxic agent and should be administered by trained healthcare professionals in a controlled clinical setting.
Before starting treatment with CYTOSAR-U, patients should inform their healthcare provider about any existing medical conditions, allergies, or medications they are taking. Pregnant or breastfeeding women should avoid this medication due to potential risks to the fetus or infant. Always consult a healthcare professional for personalized advice and guidance regarding the use of CYTOSAR-U Injection.
- Cytarabine
- Water for Injection
- Hydrochloric Acid (for pH adjustment)
- Sodium Hydroxide (for pH adjustment)
CYTOSAR-U INJECTION 20mg/ml (5ml vial) contains Cytarabine, a chemotherapy medication used primarily to treat certain types of cancer, such as acute myeloid leukemia and non-Hodgkin lymphoma. It works by interfering with the growth and spread of cancer cells in the body.
Before using CYTOSAR-U, ensure that the medication has been prescribed by a qualified healthcare professional. The dosage and administration schedule will vary depending on the patient’s condition, weight, and response to treatment. Typically, Cytarabine is administered intravenously (IV) or subcutaneously, and the injection should be prepared and administered by a trained medical professional in a clinical setting.
- Inspect the vial for any visible particles or discoloration before use. Do not use if the solution appears cloudy or contains foreign matter.
- Calculate the required dose based on the patient’s body surface area or weight, as prescribed by the doctor. The concentration of Cytarabine in this vial is 20mg per milliliter, and the total volume is 5ml.
- Using aseptic techniques, withdraw the prescribed amount of Cytarabine from the vial using a sterile syringe. Ensure the needle is properly secured to avoid leakage.
- Administer the medication slowly via intravenous infusion or subcutaneous injection, as directed. For IV administration, the solution may be diluted with a compatible IV fluid, such as normal saline or dextrose solution, if required.
- Monitor the patient closely during and after administration for any signs of adverse reactions, such as fever, chills, rash, or difficulty breathing. Immediate medical attention may be necessary in case of severe side effects.
- Dispose of any unused medication and medical supplies in accordance with local regulations and safety guidelines. Do not reuse syringes or needles.
It is essential to follow the prescribed treatment plan and attend all scheduled appointments to monitor progress and manage any side effects. Patients should inform their healthcare provider of any other medications they are taking, as Cytarabine may interact with certain drugs. Pregnant or breastfeeding women should avoid using this medication unless explicitly advised by their doctor, as it may harm the fetus or infant.
Store CYTOSAR-U Injection at room temperature, away from light and moisture. Keep the vial out of reach of children and pets. If you have any questions or concerns about the use of this medication, consult your healthcare provider for further guidance.
You may also like
Our products are sourced directly from brands or authorized distributors.
